Amazon sells a wide range of products, with new ones arriving daily across multiple categories, including everyday home goods, tech and furniture. The online retail giant also cuts prices as much as it adds products. We compile the top…
Blog
-
Fondation Cartier pour l’art contemporain opens its doors to the public
The Fondation Cartier pour l’art contemporain is a space for artistic dialogue and experimentation that places the relationship between creation and exhibition at the heart of its institutional project, working in close collaboration with…
Continue Reading
-
India football team lose 2-1 to Nepal
Minutes later, the Indian midfielder’s low free-kick was also saved.
India’s best chance of the first half came in the 32nd minute, when Grace Dangmei surged up the right and sent in a low centre towards Lynda Kom Serto.
While the latter was…
Continue Reading
-
Hyundai Motor Group and Toray Group Strengthen Ties to Develop Advanced Materials for Future Mobility
- Hyundai Motor Group and Toray Group to develop advanced materials for future mobility, including high-performance vehicles and special-purpose mobility
- Hyundai Motor Group will carry out vehicle-level design, performance evaluation and suitability assessments of advanced materials and components
- Toray Group will focus on developing intermediate materials and molded products based on its carbon fiber technologies
- The two companies will collaborate across the entire value chain in the field of high-performance composites, from R&D to production and commercialization
SEOUL, October 27, 2025 – Hyundai Motor Group and Toray Industries, Inc. (Toray Group) signed a Strategic Joint Development Agreement to collaborate on advanced materials and components innovation, aiming to set new standards in future mobility.The signing ceremony took place on October 24 at Hyundai Motor Group’s headquarters in Seoul, Korea. Key attendees included Heung-soo Kim, Executive Vice President and Head of Global Strategy Office at Hyundai Motor Group and Miki Terada, General Manager of Advanced Composites Division at Toray Group.
“This agreement marks an important milestone in our partnership, as it represents the first tangible outcome of our strategic collaboration initiated last year,” said EVP Kim. “By clearly defining our focus areas and combining our respective strengths, we will work closely together across the entire process—from R&D to production and commercialization—in the field of advanced composite materials, enhancing our ability to respond to market demands.”
Miki Terada, General Manager of Advanced Composites Division at Toray Group, also commented that “The Joint Development Agreement marks a significant step forward in advancing the partnership established in the previous year. Leveraging Toray’s unique material technologies and extensive expertise, we will collaborate closely with Hyundai Motor Group to create innovative composite solutions essential for next-generation mobility. From R&D to production and commercialization, we will work in close coordination to enhance our competitiveness in the global market.”
Building on the strategic cooperation agreement signed in April 2024, the two companies have continued to work together to develop high-performance composite materials, such as carbon fiber-reinforced plastic (CFRP), to enhance safety and performance in mobility.
Since then, the two companies have identified projects that maximize synergy through close collaboration and have outlined concrete plans for joint development by leveraging their respective strengths.
The newly signed agreement represents a major step forward in their collaboration, accelerating the development of advanced materials and components for future mobility, including high-performance vehicles as well as special-purpose mobility such as lunar exploration rovers and robots.
Hyundai Motor Group aims to accelerate innovation in future mobility and create new market opportunities through close collaboration with Toray Group across the entire value chain—from technology development to production and commercialization—in the field of high-performance composite materials.
As part of this effort, Hyundai Motor Group will carry out vehicle-level design, suitability assessments and performance evaluations of advanced materials and components through its Materials Research & Engineering Center, which is responsible for developing and validating new body materials.
The development and production of carbon fiber composites will be carried out by Toray Group’s global subsidiaries: Toray Advanced Materials Korea, Toray Advanced Composites in the Netherlands and Euro Advanced Carbon Fiber Composites in Germany. These entities focus on developing intermediate materials and molded products based on Toray Group’s carbon fiber technology.
– End –
About Toray
Toray is a leading technology and advanced materials innovator. We have contributed to social progress since our foundation in 1926 by creating new values. We help the world to overcome new challenges by supplying fibers and textiles, resins and films, carbon fiber composite materials, and other high value-added products. Our 306 subsidiaries and affiliates worldwide employ almost 48,000 people.About Hyundai Motor Group
Hyundai Motor Group is a global enterprise that has created a value chain based on mobility, steel, and construction, as well as logistics, finance, IT, and service. With about 250,000 employees worldwide, the Group’s mobility brands include Hyundai, Kia, and Genesis. Armed with creative thinking, cooperative communication, and the will to take on any challenges, we strive to create a better future for all.More information about Hyundai Motor Group can be found at: http://www.hyundaimotorgroup.com or Newsroom: Media Hub by Hyundai, Kia Global Media Center (kianewscenter.com), Genesis Newsroom
Contact:
Kyeongjin Kim
Global PR Strategy & Planning / Hyundai Motor Group
kyeongjin.kim@hyundai.comContinue Reading
-
Hyundai Motor Group and Toray Group Strengthen Ties to Develop Advanced Materials for Future Mobility
- Hyundai Motor Group and Toray Group to develop advanced materials for future mobility, including high-performance vehicles and special-purpose mobility
- Hyundai Motor Group will carry out vehicle-level design, performance evaluation and suitability assessments of advanced materials and components
- Toray Group will focus on developing intermediate materials and molded products based on its carbon fiber technologies
- The two companies will collaborate across the entire value chain in the field of high-performance composites, from R&D to production and commercialization
SEOUL, October 27, 2025 – Hyundai Motor Group and Toray Industries, Inc. (Toray Group) signed a Strategic Joint Development Agreement to collaborate on advanced materials and components innovation, aiming to set new standards in future mobility.The signing ceremony took place on October 24 at Hyundai Motor Group’s headquarters in Seoul, Korea. Key attendees included Heung-soo Kim, Executive Vice President and Head of Global Strategy Office at Hyundai Motor Group and Miki Terada, General Manager of Advanced Composites Division at Toray Group.
“This agreement marks an important milestone in our partnership, as it represents the first tangible outcome of our strategic collaboration initiated last year,” said EVP Kim. “By clearly defining our focus areas and combining our respective strengths, we will work closely together across the entire process—from R&D to production and commercialization—in the field of advanced composite materials, enhancing our ability to respond to market demands.”
Miki Terada, General Manager of Advanced Composites Division at Toray Group, also commented that “The Joint Development Agreement marks a significant step forward in advancing the partnership established in the previous year. Leveraging Toray’s unique material technologies and extensive expertise, we will collaborate closely with Hyundai Motor Group to create innovative composite solutions essential for next-generation mobility. From R&D to production and commercialization, we will work in close coordination to enhance our competitiveness in the global market.”
Building on the strategic cooperation agreement signed in April 2024, the two companies have continued to work together to develop high-performance composite materials, such as carbon fiber-reinforced plastic (CFRP), to enhance safety and performance in mobility.
Since then, the two companies have identified projects that maximize synergy through close collaboration and have outlined concrete plans for joint development by leveraging their respective strengths.
The newly signed agreement represents a major step forward in their collaboration, accelerating the development of advanced materials and components for future mobility, including high-performance vehicles as well as special-purpose mobility such as lunar exploration rovers and robots.
Hyundai Motor Group aims to accelerate innovation in future mobility and create new market opportunities through close collaboration with Toray Group across the entire value chain—from technology development to production and commercialization—in the field of high-performance composite materials.
As part of this effort, Hyundai Motor Group will carry out vehicle-level design, suitability assessments and performance evaluations of advanced materials and components through its Materials Research & Engineering Center, which is responsible for developing and validating new body materials.
The development and production of carbon fiber composites will be carried out by Toray Group’s global subsidiaries: Toray Advanced Materials Korea, Toray Advanced Composites in the Netherlands and Euro Advanced Carbon Fiber Composites in Germany. These entities focus on developing intermediate materials and molded products based on Toray Group’s carbon fiber technology.
– End –
About Toray
Toray is a leading technology and advanced materials innovator. We have contributed to social progress since our foundation in 1926 by creating new values. We help the world to overcome new challenges by supplying fibers and textiles, resins and films, carbon fiber composite materials, and other high value-added products. Our 306 subsidiaries and affiliates worldwide employ almost 48,000 people.About Hyundai Motor Group
Hyundai Motor Group is a global enterprise that has created a value chain based on mobility, steel, and construction, as well as logistics, finance, IT, and service. With about 250,000 employees worldwide, the Group’s mobility brands include Hyundai, Kia, and Genesis. Armed with creative thinking, cooperative communication, and the will to take on any challenges, we strive to create a better future for all.More information about Hyundai Motor Group can be found at: http://www.hyundaimotorgroup.com or Newsroom: Media Hub by Hyundai, Kia Global Media Center (kianewscenter.com), Genesis Newsroom
Contact:
Kyeongjin Kim
Global PR Strategy & Planning / Hyundai Motor Group
kyeongjin.kim@hyundai.comContinue Reading
-
Hilary Duff Teases New Music Will Be Released ‘Really Soon’
After more than decade since her last studio album, Hilary Duff is getting ready to put out new music.
“We’re getting something really soon,” she teased when I caught up with her at Vogue World: Hollywood 2025 on Sunday night in Los…
Continue Reading
-
How AI and cell data combine to make drug discovery faster
Cellarity has published a new paper in detailing an AI-powered framework that integrates single-cell transcriptomics to make drug discovery faster and more successful.
Cellarity, a biotechnology company pioneering Cell…
Continue Reading
-
Critical Dell Storage Manager flaws could let hackers access sensitive data – patch now
Dell Technologies has issued a warning to customers after the discovery of critical vulnerabilities in its Storage Manager service.
The three flaws, tracked as CVE-2025-43995, CVE-2025-43994, and CVE-2025-46425, command CVSS scores of 9.8, 8.6,…
Continue Reading
-
IDWeek 2025: novel phage AP-SA02 leads to earlier resolution of S. aureus bacteremia
At IDWeek 2025, held on 19–22 October, Dr Loren Miller from Harbor-UCLA Medical Center/Lundquist Institute presented efficacy and safety data from a Phase Ib/IIa randomised, placebo-controlled trial investigating Armata Pharmaceuticals’ intravenous bacteriophage cocktail, AP-SA02, in adult patients with bacteremia caused by Staphylococcus aureus.
Bacteriophages, or phages, are viruses that can selectively target and kill bacteria. They work by infecting specifically targeted bacteria with phage DNA. This allows the phage to replicate inside of the host cell, produce phage offspring, and then lyse the bacterial cell to release the new phages. Phages are particularly advantageous anti-infectives as they are novel therapeutics, can target antibiotic-resistant bacteria, can be used as monotherapy or combination therapy, and do not cause microbiome disruption in patients.
S. aureus is a commensal bacterium and part of the natural human microbiome in approximately 30% of people. Conversely, S. aureus can lead to serious infections, particularly in those with chronic health conditions, in intensive care units (ICUs), or with weakened immune systems. Staphylococcus aureus bacteremia (SAB) can lead to serious bloodstream infections, including cellulitis, sepsis, and endocarditis. The World Health Organization (WHO) categorised methicillin-resistant S. aureus (MRSA) as a high-priority pathogen in the 2024 WHO Bacterial Priority Pathogens List.
The Phase IIa portion of the diSArm trial (NCT05184764) included 42 patients who were 18 years of age or older and had been hospitalized and diagnosed with a positive blood culture for S. aureus. These patients were randomised into two groups: those receiving intravenous AP-SA02 at a dose of 2×10¹⁰ plaque forming units (PFU) or 5×10¹⁰ PFU every six hours for five days, in addition to intravenous standard of care (SOC) best available antibiotic therapy (BAT) for 14–56 days, or those in the placebo group receiving SOC BAT for 14–56 days. Test-of-cure (TOC) screenings were performed seven days after the end of AP-SA02 (Day 12), seven days after the end of BAT (Day 18–60), and 28 days after the end of BAT (Day 39–81).
The site of infections in the patients in the study included septic joint, cellulitis, osteomyelitis, pneumonia, sepsis, and endocarditis; 19 of the patients tested positive for MRSA. The BAT antibiotics included cefazolin, vancomycin, oxacillin/nafcillin, daptomycin, cefepime, and ceftriaxone; some patients received more than one antibiotic.
At all TOC screenings, the clinical response in patients receiving AP-SA02 plus BAT was higher than in patients who had received the placebo plus BAT, including in patients with MRSA and methicillin-susceptible S. aureus (MSSA). On average, the AP-SA02 plus BAT–treated patients observed an initial resolution of their SAB infection in 2.7 days, compared to 9.3 days in the placebo plus BAT–treated group. Additionally, the AP-SA02 plus BAT–treated patients were discharged from the hospital after approximately 11.7 days and had a mean C-reactive protein level of 50.2mg/l on Day 12, compared to 19.2 days and 97.3mg/l, respectively, in the placebo plus BAT group.
Overall, AP-SA02 was found to be generally safe and well tolerated. Adverse events (AEs) were observed in 66% of patients who received the AP-SA02 plus BAT therapy, and treatment-emergent AEs (TEAEs) were observed in 59% of these patients. Only one patient was reported as having study drug–related TEAEs. One patient death was reported in the AP-SA02 plus BAT group, but this was found to be unrelated to infection, the study drug, or the BAT antibiotic.
The results of the Phase IIa trial support AP-SA02’s advancement into Phase III development. Armata Pharmaceuticals plans to initiate this pivotal study in 2026. The clinical success of AP-SA02 highlights its potential to fulfil a critical need for SAB patients.
Continue Reading
-
ABB FIA FORMULA E WORLD CHAMPIONSHIP RETURNS TO VALENCIA FOR FIVE DAYS OF PRE-SEASON TESTING
ABB FIA FORMULA E WORLD CHAMPIONSHIP RETURNS TO VALENCIA FOR FIVE DAYS OF PRE-SEASON TESTING
The ABB FIA Formula E World Championship returns to Valencia for the first time since 2023 for…
Continue Reading